The implementation of a contamination control strategy in accordance with Annex 1 brings a number of benefits for the pharmaceutical industry:
The strategy ensures stringent control over the entire manufacturing process, resulting in increased safety and quality of pharmaceutical products and defines clear guidelines that meet regulatory standards. By implementing this strategy, companies can ensure that their production practices comply with regulatory requirements. The contamination control strategy aims to ensure quality during the manufacturing of pharmaceuticals. Through comprehensive risk assessment, potential sources of contamination can be identified and appropriate measures can be taken to minimize the risk of contamination. The contamination control strategy promotes efficient manufacturing practices by providing clear guidance on the use of cleanroom technologies, validation procedures and training programs, among other things.